The available evidence of an increased risk of seizures in patients treated with bupropion for depression was inconclusive. This evidence was, however, limited to uncontrolled studies rated as low quality by the authors of the AHRQ systematic review.
The absence of data from controlled trials may be a consideration when deciding on the criteria for use of bupropion in patients with depression.